Clinical Trials Logo

Clinical Trial Summary

Kidney and Pancreas transplantation is considered the treatment of choice for many people with End Stage Renal Disease and Type 1 diabetes because quality of life and survival is often better after transplantation. However the quality of organs varies as does the quality of perfusion once they are transplanted. The immediate determinant of the survival of any transplanted allograft often depends on the overall quality of perfusion of the organ. The assessment of perfusion is currently visually and empirically done and reported by the surgical team, with low objectivity. The Laser Speckle Doppler technique will be used in both kidney and pancreas transplantation to objectively study the quality of blood flow to the kidney and pancreas after transplantation. This Doppler will provide continuous, non-invasive blood flow monitoring of the microvascular environment of the transplanted organ. The strength of the technique is in evaluating changes in flow over an area of interest or the whole transplanted organ and accurately numerically quantifying the flow. The laser speckle Doppler technique is now well established and has been used in various clinical and research setting as the most convenient means of assessing tissue blood flow. It has however not yet been used in kidney and pancreas transplantation.


Clinical Trial Description

BACKGROUND After reperfusion in solid organ transplantation, the quality of organ reperfusion is often assessed visually and reported as good, moderate, reasonable, patchy or poor. In our centre a Renogram is usually performed which uses radioactive tracer which most kidney transplant recipients would have within 24 hours after transplantation to assess the overall perfusion of the allograft. The Speckle Laser Doppler is a powerful clinical tool to obtain full field, high resolution images of microvascular perfusion of an organ It has been used in many medical fields such as dermatology vascular medicine and neurosciences both in a research and in clinical settings. This study seeks to utilise this technique to try to accurately quantify perfusion in the kidney and pancreas after transplantation and to develop a robust numerical quantification system of reporting on organ perfusion. The Speckle Laser Doppler blood flow imager uses the laser speckle contrast technique to deliver real-time blood flow images with numerical physical data, providing outstanding performance in a wide range of pre-clinical and clinical research applications. This technique has not yet been applied for the assessment of kidney transplant perfusion reporting. RESEARCH QUESTION/AIM(S) 1. To evaluate the use of the laser blood flow imager in both kidney and pancreas transplantation and obtain real time video images with physical parametric data of the blood flow of transplanted organs at the time of transplantation as a proof of principle study to accurately quantify the blood flow rate either in the whole transplanted organ or a specific area of interest so as to develop a robust numerical quantification system of reporting on the perfusion of the transplanted organ. While this technique has been used in neurosurgery and other clinical settings it has not been evaluated before in a transplant setting. . 2. Measure the markers of inflammation (Hypo perfusion) and oxidative stress and attempt correlation with the quality of perfusion obtained. Objectives This study aims to utilise this technique to try to accurately quantify perfusion in the kidney and pancreas after transplantation and to develop a robust numerical quantification system of reporting on organ perfusion Outcome Circulating markers of hypo perfusion and kidney injury will be measured to include: lactate, glutamate, pyruvate, Interleukin 6 as well as glutathione a marker of oxidative stress and assess their correlation with outputs from the two devices. RATIONALE This study seeks to utilise this technique to try to accurately quantify perfusion in the kidney and pancreas after transplantation and to develop a robust numerical quantification system of reporting on organ perfusion. The moorFLPI-2 blood flow imager uses the laser speckle contrast technique to deliver real-time blood flow images with numerical physical data, providing outstanding performance in a wide range of pre-clinical and clinical research applications. This technique has not yet been applied for the assessment of kidney transplant perfusion reporting. STUDY DESIGN and METHODS of DATA COLLECTION AND DATA ANALYIS Speckle Doppler The Speckle Laser Doppler blood flow imager will be used to obtain real-time blood flow images at reperfusion and immediately thereafter this imaging will occur immediately after the surgery when the patient is still under anaesthetic it will take approximately 15 minutes. Initially these images with the flow parametric data will be stored on a laptop which comes with the rental equipment. However once the study is complete, all images and data will be stored on a desktop/drive in the department along with other departmental research data confidentially. The software integrated in the equipment incorporates multiple blood flow parameters and a statistical analytical package for an exhaustive analysis of various parameters. The Speckle Laser Doppler has two low power visible aiming lasers that indicate the approximate centre of the image. The aiming lasers will appear as a single point at a distance of 25 cm. As the distance is increased or decreased from 25 cm, the aiming lasers will appear as two separate points with the centre of the image being located at the midpoint between them. The aiming lasers can be turned on or off by pressing the button on the scan head or from the System Setup window in the PC software. The moorFLPI-2 measurement software provides two measurement modes that can be used separately or in combination: - Multi-image measurement mode. - Single point measurement mode. The multi-image mode setting will be used as it measures flux over regular timed intervals and that is what is required for us to quantify the perfusion as compared to a single point measurement mode which measures the average flux at a single point in time. Blood samples Concurrently blood samples will be obtained on each patient on Day 0 (day of transplantation), after reperfusion to measure markers of hypo perfusion and kidney injury: lactate, glutamate, pyruvate, Interleukin 6 as well as glutathione a marker of oxidative stress Clinical Follow up Patients will be monitored for 3 years following their transplant to look for any transplant related problems which may relate to the quality of the organ as assessed by speckle Doppler. Sample size and Statistical analysis This is an exploratory study to evaluate the use of Doppler in kidney transplants and as such sample size is mainly dictated by pragmatic considerations and what is available for the duration of hiring the device. Nevertheless sample of 68 is sufficient to provide reasonable precision for the agreement and correlation tests intended for this study in an exploratory level. The analyses will be mainly descriptive. Tests will be exploratory and in the view of generating information for future larger studies. Research Q1 The software integrated in the equipment incorporates multiple blood flow parameters and a statistical analytical package for an exhaustive analysis of various parameters. The comparison between the 2 methods for measuring blood flow will be assessed for agreement using the appropriate statistical methodology. The continuous variables for markers of inflammation, circulating markers of hypo perfusion and oxidative stress will also be assessed for any correlation with speckle Doppler perfusion measurements. Events at the end of 3 years follow up will be compared with the blood flow measurements in categorical analysis. STUDY SETTING Our unit performs the largest number of kidneys transplants in the UK so has access to a large number of samples for this project. All members of the team have academic track records and participate in several on-going research projects. Current research projects are investigating cardiovascular disease, kidney perfusion, and MR imaging. ;


Study Design


Related Conditions & MeSH terms

  • Kidney Transplant Failure and Rejection

NCT number NCT04202237
Study type Observational
Source Manchester University NHS Foundation Trust
Contact
Status Completed
Phase
Start date December 6, 2019
Completion date July 30, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04057742 - AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation
Recruiting NCT03465397 - Individualization of the Immunological Risk Based on Selective Biomarkers in Living-donor Renal Recipients Phase 4
Completed NCT03437577 - Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients Phase 1/Phase 2
Not yet recruiting NCT05282966 - Assessment of QSantâ„¢ for Underlying Allograft Rejection
Recruiting NCT04388930 - The Microbiota in Kidney Donation and Transplantation
Completed NCT03611621 - A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation
Recruiting NCT05397821 - Pediatric Kidney Transplantation, Ureteroneocystostomy Techniques
Completed NCT04019353 - Cf-DNA Assay During Treatment of Acute Rejection
Recruiting NCT05806749 - Immunological Tolerance in Patients With Mismatched Kidney Transplants Phase 1
Recruiting NCT04936282 - Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING) Phase 4
Enrolling by invitation NCT05285878 - Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation Phase 2
Recruiting NCT04526431 - Tacrolimus Pharmacokinetic Subpopulations
Active, not recruiting NCT03511560 - Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation Phase 4
Recruiting NCT03438773 - Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients Phase 1
Completed NCT05388955 - Risk Assessment Tool for Graft Survival in Pediatric Kidney Transplantation
Completed NCT04413916 - MiRNA in Kidney Transplantation: Association With Kidney Graft Function and Disease Process
Completed NCT03466775 - Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes N/A
Active, not recruiting NCT04733131 - Long-term Outcomes After Conversion to Belatacept
Active, not recruiting NCT03380962 - Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant Phase 1/Phase 2
Active, not recruiting NCT04154267 - Protocol Biopsies in High-risk Renal Transplant Recipients N/A